CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback